Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Mid-Castle Development Limited | SFWL SHENGFENG DEVELOPMENT Ltd | 13G | 9% | Dec 31, 2023 | 2y |
| Aqua Capital, Ltd. | ENR Energizer Holdings, Inc. | 13G/A | 8.72% | Dec 31, 2023 | 2y |
| Morgan Callagy | CSLM CSLM Acquisition Corp. Class A Ordinary Share | 13G | 19.33% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | KZR Kezar Life Sciences, Inc. | 13G/A | 2.7% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | RPD Rapid7, Inc. | 13G/A | 3.1% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | XMTR Xometry, Inc. | 13G/A | 13.15% | Dec 31, 2023 | 2y |
| MACQUARIE GROUP LTD | MCB Metropolitan Bank Holding Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | FIVE Five Below, Inc | 13G | 5.4% | Dec 31, 2023 | 2y |
| Greenhouse Funds LLLP | CLAR Clarus Corp | 13G/A | 11.9% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | BYNO byNordic Acquisition Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Atreides Management, LP | SOND Sonder Holdings Inc. Class A Common Stock | 13G/A | 9.15% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | BCYC Bicycle Therapeutics PLC | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CB Chubb Ltd | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| EdgePoint Investment Group Inc. | XPL Solitario Resources Corp. | 13G | 9.3% | Dec 31, 2023 | 2y |
| Strategic Value Investors LP | SSBK Southern States Bancshares, Inc. Common | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| Alger Associates, Inc. 13-3017981 | NVRO NEVRO CORP. | 13G | 5.8% | Dec 31, 2023 | 2y |
| Broad Bay Capital Management, LP | MAX MediaAlpha, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | NWSA News Corp | 13G/A | 17.2% | Dec 31, 2023 | 2y |
| Global X Management CO LLC | URG Ur-Energy Inc | 13G | 5.32% | Dec 31, 2023 | 2y |
| Mark N. Tompkins | GUER Guerrilla RF, Inc. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | TLGYF Tlgy Acquisition Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | TDY Teledyne Technologies Inc | 13G | 5.9% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | ADEA Adeia Inc. | 13G/A | 12.53% | Dec 31, 2023 | 2y |
| EVENTIDE ASSET MANAGEMENT, LLC | INZY Inozyme Pharma, Inc. Common Stock | 13G | 5.15% | Dec 31, 2023 | 2y |
| Kishon Eyal | VLN Valens Semiconductor Ltd. | 13G/A | 0.32% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | GTEC Greenland Technologies Holding Corp. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| P SCHOENFELD ASSET MANAGEMENT LP | TRTL TortoiseEcofin Acquisition Corp. III | 13G/A | 3.2% | Dec 31, 2023 | 2y |
| Griffith Curtis C | SPFI South Plains Financial, Inc. | 13G/A | 14.03% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | ASCA A SPAC I Acquisition Corp. Class A Ordinary Share | 13G/A | 4.19% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | CALX Calix, Inc | 13G | 8% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | RLYB Rallybio Corp | 13G/A | 11.1% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | GTAC Global Technology Acquisition Corp. I Class A Ordinary Shares | 13G/A | 0.71% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13G | 6.32% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | SGA Saga Communications Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| Teachers Advisors, LLC | ADMA Adma Biologics, Inc. | 13G | 2.24% | Dec 31, 2023 | 2y |
| D. VICTOR PERLROTH, M.D. | KOD Kodiak Sciences Inc. | 13G/A | 10.4% | Dec 31, 2023 | 2y |
| Whitefort Capital Management, LP | GSL Global Ship Lease, Inc. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| FPR PARTNERS LLC | LBRDK Liberty Broadband Corp | 13G/A | 6% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | QOMO Qomolangma Acquisition Corp. Common Stock | 13G | 6.83% | Dec 31, 2023 | 2y |
| Eric S. Yuan | ZM Zoom Communications, Inc. | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| I-Pulse Inc. | IE Ivanhoe Electric Inc. | 13G/A | 2.8% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | LXRX Lexicon Pharmaceuticals, Inc. | 13G/A | 9.98% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SMG Scotts Miracle-Gro Co | 13G | 3.9% | Dec 31, 2023 | 2y |
| Clal Insurance Enterprises Holdings Ltd | PERI Perion Network Ltd. | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| FRONTIER CAPITAL MANAGEMENT CO.,LLC | PAY Paymentus Holdings, Inc. | 13G/A | 5.14% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | ALXO Alx Oncology Holdings Inc | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| Joel E. Cutler | OSCR Oscar Health, Inc. | 13G/A | 1.1% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | ASBP Aspire-Lakewood Holdings, Inc. | 13G/A | 0.34% | Dec 31, 2023 | 2y |
| MOORE CAPITAL MANAGEMENT, LP | BLEU bleuacacia ltd Class A Ordinary Shares | 13G | 9.5% | Dec 31, 2023 | 2y |
| AI EIPP Holdings LLC | CRVO CervoMed Inc. | 13G/A | 7.49% | Dec 31, 2023 | 2y |